CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 
 

SCPH's EPS from Cont. Operations Growth by Quarter and Year

Scpharmaceuticals Inc 's EPS from Cont. Operations results by quarter and year




SCPH EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.27 -0.28 -0.58
III Quarter September -0.37 -0.24 -0.33 -0.33
II Quarter June -0.35 -0.26 -0.36 -0.39
I Quarter March -0.28 -0.26 -0.35 -0.47
FY   -1.00 -1.03 -1.32 -1.77



SCPH EPS from Cont. Operations third quarter 2022 Y/Y Growth Comment
Scpharmaceuticals Inc in the third quarter 2022 recorded EPS loss from Cont. Operations of $ -0.37 .

According to the results reported in the third quarter 2022, Scpharmaceuticals Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Scpharmaceuticals Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




SCPH EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scpharmaceuticals Inc 's third quarter 2022 EPS from Cont. Operations $ -0.37 SCPH's Income Statement
Scpharmaceuticals Inc 's third quarter 2021 EPS from Cont. Operations $ -0.24 Quarterly SCPH's Income Statement
New: More SCPH's historic EPS from Cont. Operations Growth >>


SCPH EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scpharmaceuticals Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q EPS from Cont. Operations Comment
III. Quarter 2022 results of -0.37 by Scpharmaceuticals Inc appear even worse if you take a look at -0.35 EPS loss from Cont. Operations in the second quarter.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While Scpharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q EPS from Cont. Operations Comment
III. Quarter 2022 EPS loss from Cont. Operations of -0.37 by Scpharmaceuticals Inc come out even worse considering the -0.35 in the second quarter.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential EPS from Cont. Operations growth. While Scpharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Scpharmaceuticals Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -1.27 $ -1.14 $ -1.05 $ -1.03 $ -1.04
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2022 period.
The business is getting worse as the cumulative EPS loss from Cont. Operations is inflating from $ -1.14 in the twelve months ending a quarter before and $ -0.35 from the TTM period ending Sep 30 2021.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2022 period.
The situation is worsening as the cumulative EPS loss from Cont. Operations is becoming larger from $ -1.14 in the twelve months ending a quarter before and $ -0.35 from the TTM period ending Sep 30 2021 Jeremiah Ramsey mentioned.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
SCPH's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for SCPH's Competitors
EPS from Cont. Operations Growth for Scpharmaceuticals Inc 's Suppliers
EPS from Cont. Operations Growth for SCPH's Customers

You may also want to know
SCPH's Annual Growth Rates SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2022
Lsi Industries Inc 91.67%$ 91.667 
Abiomed Inc 87.20%$ 87.200 
Stryker Corp84.62%$ 84.615 
Fonar Corporation81.25%$ 81.250 
Universal Security Instruments Inc80.00%$ 80.000 
Medpace Holdings Inc 57.78%$ 57.778 
Vir Biotechnology Inc 55.29%$ 55.294 
United Therapeutics Corporation45.30%$ 45.304 
Royalty Pharma Plc33.33%$ 33.333 
Eli Lilly And Company31.97%$ 31.967 
Zimmer Biomet Holdings Inc 31.43%$ 31.429 
Iradimed Corporation28.57%$ 28.571 
Merit Medical Systems Inc28.57%$ 28.571 
Bio techne Corp28.09%$ 28.090 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HILS's Profile

Stock Price

HILS's Financials

Business Description

Fundamentals

Charts & Quotes

HILS's News

Suppliers

HILS's Competitors

Customers & Markets

Economic Indicators

HILS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071